A Google-owned AI lab advancing science and healthcare through breakthroughs like AlphaFold and AlphaGo.
3.8M visits/mo-3.7%#43 Coding & Development
Personalized Analysis and Treatment of Heart Disease
AI-powered platform that analyzes coronary CT scans to detect and quantify heart disease with personalized treatment recommendations.
7.8KMonthly visits
15Popularity
About Personalized Analysis and Treatment of Heart Disease
Cleerly is an AI-driven medical platform designed to analyze coronary CT angiography scans to detect, quantify, and characterize coronary artery disease. The system uses a fine-tuned foundation model to provide detailed, patient-specific assessments of plaque buildup, stenosis severity, and overall cardiovascular risk. Clinicians can use Cleerly to generate automated reports that highlight areas of concern, reducing manual interpretation time and improving diagnostic accuracy. The platform supports shared decision-making by offering tailored treatment recommendations based on the AI analysis. It is intended for cardiologists, radiologists, and other healthcare professionals involved in cardiovascular care. Cleerly integrates into existing clinical workflows, enabling faster and more consistent evaluation of coronary artery disease compared to traditional methods. The tool is particularly valuable in settings where high-volume CT imaging requires efficient and reproducible analysis.
Key features
- Automated coronary artery plaque detection and quantification
- Stenosis severity assessment with AI-generated measurements
- Personalized treatment recommendations based on scan findings
- Integration with existing clinical workflows and imaging systems
- Detailed, structured reports for cardiologists and radiologists
- Support for shared decision-making in cardiovascular care
- Fine-tuned foundation model for high accuracy in coronary analysis
- Reduces manual interpretation time for CT angiography scans
Use cases
- Automated analysis of coronary CT scans for suspected coronary artery disease
- Quantification of plaque burden and stenosis in high-risk patients
- Supporting cardiologists in developing personalized treatment plans
Pros
- Provides comprehensive quantification of coronary artery disease (CAD) by measuring plaque volume, composition, length, and location
- Evaluates stenosis severity in both 2D and 3D, enhancing diagnostic precision
- Demonstrates higher diagnostic accuracy compared to FFRCT and stress testing in clinical trials
- Offers workflow for determining likely presence or absence of ischemia, potentially reducing additional testing
- Delivers clinically actionable insights through a web-based solution for healthcare providers
Cons
- Requires integration into existing clinical workflows, which may involve training and adaptation
- Dependent on high-quality coronary CT angiography (CCTA) scans for accurate analysis
Frequently asked questions about Personalized Analysis and Treatment of Heart Disease
What does Cleerly do?
Cleerly is an AI-driven platform that analyzes coronary CT angiography scans to quantify and assess coronary artery disease, providing detailed insights on plaque characteristics, stenosis severity, and potential ischemia.
Who is Cleerly designed for?
The platform is intended for cardiologists, radiologists, and other healthcare professionals involved in cardiovascular care who need accurate and efficient analysis of coronary artery disease.
How does Cleerly integrate into clinical workflows?
Cleerly provides automated reports and tailored treatment recommendations based on AI analysis, reducing manual interpretation time and supporting shared decision-making in patient care.
Does Cleerly require additional testing for patients?
The platform aims to reduce the need for additional testing by providing comprehensive insights on plaque and stenosis, potentially improving diagnostic confidence without further procedures.
What evidence supports Cleerly's accuracy?
Cleerly ISCHEMIA demonstrated higher diagnostic accuracy in the CREDENCE trial and outperformed other non-invasive tests in predicting future major adverse cardiac events (MACE) in the PACIFIC study.
How can healthcare providers get started with Cleerly?
Providers can request a demo or contact Cleerly to explore implementation, integration, and workflow adaptation for their practice.
Personalized Analysis and Treatment of Heart Disease traffic & engagement
cleerlyhealth.com · third-party estimates from Similarweb
Data as of Sep 2026Full AI website ranking →
Monthly visits · Sep 20267.8K-40.7% MoM12-month high 43K (Jun 2026)
Rank among AI websites#4,756▼ 647 vs last monthof 8,652 tools on aitoolnavio™
Top marketUnited States92.2%Top 4 countries bring 100% of visits
Average visit4m 50sLonger than 91% of AI sites
Pages per visit2.51More than 70% of AI sites
Bounce rate36%Lower than 72% of AI sites
Similarweb global rank#2,396,164#745,377 in United States
Traffic trend
Last 4 months · grows by one month every month
- Jun 202643K
- Jul 202627K−35.9%
- Aug 202613K−51.9%
- Sep 20267.8K−40.7%
Where visitors come from
Share of visits by channel
No measurable traffic from Paid Referrals.
Top countries
Share of visits · estimated visits
Compared with similar tools
Lifestyle & Education · Sep 2026
Traffic figures are third-party estimates, good for scale and trends; they can differ from a company's own numbers. Updated monthly.
